FreeTheAI

Lantern Pharma, Inc.

LTRN · NASDAQ · USD

$0.8127

−0.0173 −2.08%todayNot financial advice.

LTRN Price chart 5Y
Open
0.8300
Day range
0.7603 - 0.8301
52-week range
0.7603 - 4.58
Volume
274.88K
Market cap
12.14M
P/E ratio
—
EPS
-1.61
Dividend yield
0.00%
Beta
4.84

Performance

W

−21.10%

1M

−55.35%

3M

−76.10%

6M

−57.67%

YTD

−73.00%

Y

−82.48%

5Y

−92.22%

All

−94.51%

In the news

  1. Oct 7

    Lantern Pharma Wins Taiwan Approvals to Open Part 2 of Phase 2 Cancer Trial

    Lantern Pharma secured regulatory clearances in Taiwan to advance the Phase 2 trial of its lung cancer drug candidate, LP-300, into its second part.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-LTRN" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Lantern Pharma, Inc. (LTRN) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-LTRN">LTRN stock price</a> by FreeTheAI Stocks</p>